Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: What are the current options?;Diagnostic et traitement des adénocarcinomes de la jonction œsogastrique non métastatiques: Quels standards actuels?

Journal de Chirurgie Viscerale

Volumn 149, Issue 1, 2012, Pages 25-35

  Gronnier, C ^a   Piessen, G ^a   Mariette, C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Adenocarcinoma; Chemotherapy; Esophagogastric junction; Radiotherapy; Surgery

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GASTRECTOMY; GASTROSCOPY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; REVIEW; STOMACH TUMOR;

ADENOCARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; GASTRECTOMY; GASTROSCOPY; HUMANS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 84868088829     PISSN: 1878786X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchirv.2011.12.005     Document Type: Short Survey

References (57)

1. D.A. Corley, and P.A. Buffler Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database Int J Epidemiol 30 2001 1415 1425 (Pubitemid 34134300)
2. W.J. Blot, S.S. Devesa, R.W. Kneller, and J.F. Fraumeni Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
3. E. Bollschweiler, E. Wolfgarten, C. Gutschow, and A.H. Hölscher Demographic variations in the rising incidence of esophageal adenocarcinoma in white males Cancer 92 2001 549 555 (Pubitemid 32735190)
4. C. Mariette, J.M. Balon, G. Piessen, S. Fabre, I. Van Seuningen, and J.P. Triboulet Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease Cancer 97 2003 1616 1623 (Pubitemid 36350704)
5. M. Sasako Principles of surgical treatment for curable gastric cancer J Clin Oncol 21 2003 274s 275s
6. H.J. Stein, M. Feith, J. Mueller, M. Werner, and J.R. Siewert Limited resection for early adenocarcinoma in Barrett's esophagus Ann Surg 232 2000 733 742
7. Thésaurus national de cancérologie digestive. Chapitres cancer de l'œsophage et cancer l'estomac. http://www.snfge.asso.fr/01- Bibliotheque/0GThesaurus-cancerologie/publication5/sommaire-thesaurus.asp.
8. R.T. Poon, S.Y. Law, K.M. Chu, F.J. Branicki, and J. Wong Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management Ann Surg 227 1998 357 364 (Pubitemid 28131016)
9. th Edition 2009 Wiley-Liss New York
10. E.P. van Vliet, M.H. Heijenbrok-Kal, M.G. Hunink, E.J. Kuipers, and P.D. Siersema Staging investigations for oesophageal cancer: a meta-analysis Br J Cancer 98 2008 547 557 (Pubitemid 351214529)
11. C.J. Lightdale, and K.G. Kulkarni Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer J Clin Oncol 23 2005 4483 4489 (Pubitemid 46196577)
12. F. Lordick, K. Ott, and B.J. Krause PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 8 2007 797 805 (Pubitemid 47308659)
13. O. Pech, A. May, T. Rabenstein, and C. Ell Endoscopic resection of early oesophageal cancer Gut 56 2007 1625 1634 (Pubitemid 350033204)
14. S.R. DeMeester Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment Ann Surg Oncol 13 2006 12 30
15. Okines, A.R. Norman, P. McCloud, Y.K. Kang, and D. Cunningham Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer Ann Oncol 2009 1529 1534
16. Holscher, U. Drebber, S.P. Mönig, C. Schulte, D. Vallböhmer, and E. Bollschweiler Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration Ann Surg 250 2009 791 797
17. P. Hermanek pTNM and residual tumor classifications: problems of assessment and prognostic significance World J Surg 19 1995 184 190
18. Medical Research Council Oesophageal Cancer Working Group Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial Lancet 359 2002 1727 1733
19. D.P. Kelsen, K.A. Winter, and L.L. Gunderson Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer J Clin Oncol 25 2007 3719 3725 (Pubitemid 47372613)
20. J.R. Siewert, M. Feith, M. Werner, and H.J. Stein Adenocarcinoma of the oesophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients Ann Surg 232 2000 353 361
21. A. Peracchia, and L. Bonavina Outcome of surgical treatment A. Perrachia, L. Bonavina, Adenocarcinoma of the esophagogastric junction. 2000 EDRA Milan 151 169
22. A. Sauvanet, C. Mariette, and J.P. Triboulet Cancer du cardia. Rapport de l'AFC 2003 2003 Ed Arnette Paris p. 73-109
23. M. Feith, H.J. Stein, and J.R. Siewert Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients Surg Oncol Clin N Am 15 2006 751 764 (Pubitemid 44499032)
24. T. Lerut Esophageal surgery at the end of the millennium J Thorac Cardiovasc Surg 116 1998 1 20 (Pubitemid 28328622)
25. C. Mariette, B. Castel, H. Toursel, S. Fabre, J.M. Balon, and J.P. Triboulet Surgical management of and long-term survival after adenocarcinoma of the cardia Br J Surg 89 2002 1156 1163 (Pubitemid 34989223)
26. S.M. Dresner, P.J. Lamb, M.K. Bennett, N. Hayes, and S.M. Griffin The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction Surgery 129 2001 103 109 (Pubitemid 32099263)
27. P.C. Wu, and M.C. Posner The role of surgery in the management of oesophageal cancer Lancet Oncol 4 2003 481 488 (Pubitemid 37009956)
28. K. Slim, J.Y. Blay, and A. Brouquet Digestive oncology: surgical practices. J Chir (Paris) 146 Suppl 2 2009 S11 S80
29. J.B. Hulscher, J.W. van Sandick, and A.G. de Boer Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 2002 1662 1669 (Pubitemid 35340784)
30. J.M. Omloo, S.M. Lagarde, and J.B. Hulscher Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial Ann Surg 246 2007 992 1000 (Pubitemid 350179188)
31. M. Sasako, T. Sano, and S. Yamamoto Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial Lancet Oncol 7 2006 644 651 (Pubitemid 44123569)
32. A. Sauvanet, C. Mariette, and P. Thomas Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors J Am Coll Surg 201 2005 253 262 (Pubitemid 40994960)
33. R.C. Martin 2nd, D.P. Jaques, M.F. Brennan, and M. Karpeh Extended local resection for advanced gastric cancer: increased survival versus increased morbidity Ann Surg 236 2002 159 165 (Pubitemid 34809534)
34. E.H. Gemmill, and P. McCulloch Systematic review of minimally invasive resection for gastro-oesophageal cancer Br J Surg 94 2007 1461 1467 (Pubitemid 350275623)
35. Mariette C. Open versus laparoscopically-assisted esophagectomy for cancer. http://clinicaltrials.gov/ct2/show/NCT00937456 [accessed Jan 6, 2010].
36. A. Falcone Future strategies and adjuvant treatment of gastric cancer Ann Oncol 14 2003 ii45 ii47
37. P. Sun, J.B. Xiang, and Z.Y. Chen Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer Br J Surg 96 2009 26 33
38. D.P. Kelsen, R. Ginsberg, and T.F. Pajak Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1998 1979 1984 (Pubitemid 29024130)
39. W.H. Allum, S.P. Stenning, J. Bancewicz, P.I. Clark, and R.E. Langley Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 2009 5062 5067
40. D. Cunningham, W.H. Allum, and S.P. Stenning Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
41. V. Boige, J. Pignon, and B. Saint-Aubert Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatine (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial Proc Am Soc Clin Oncol 25 2007 abstr 4510
42. P.G. Thirion, S. Michiels, A. Le Maître, J. Tierney on behalf of the Metaanalysis of Chemotherapy in Esophagus Cancer Collaborative Group Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma Proc Am Soc Clin Oncol 25 2007 abstr 4512
43. T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467 (Pubitemid 26269945)
44. S.G. Urba, M.B. Orringer, A. Turrisi, M. Iannettoni, A. Forastiere, and M. Strawderman Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313 (Pubitemid 32112841)
45. B.H. Burmeister, B.M. Smithers, V. Gebski for the Trans-Tasman Radiation Oncology Group (TROG) and the Australasian Gastro- Intestinal Trials Group (AGITG) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 2005 659 668 (Pubitemid 41222756)
46. J. Tepper, M.J. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fl uorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
47. P.G. Thirion, E. Maillard, J. Pignon Group 2 M.A., of Chemo in Oesophagus Cancer Collaborative Group Individual patient databased meta-analysis assessing the effect of preoperative chemoradiotherapy in resectable oesophageal carcinoma Int J Radiat Oncol Biol Phys 72 2008 S71 S72
48. A.V. Gaast, P. Van Hagen, and M. Hulshof Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study Proc Am Soc Clin Oncol 28 2010 abstr 4004
49. C. Mariette, J.F. Seitz, and E. Maillard Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901 J Clin Oncol 28 2010 15s [suppl; abstr 4005]
50. L.L. Gunderson Gastric cancer - patterns of relapse after surgical resection Semin Radiat Oncol 12 2002 150 161 (Pubitemid 34522351)
51. M.T. Hallissey, J.A. Dunn, L.C. Ward, W.H. Allum for the British Stomach Cancer Group The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up Lancet 343 1994 1309 1312
52. J.S. Macdonald, S.R. Smalley, and J. Benedetti Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
53. J.S. Macdonald, J. Benedetti, and S. Smalley Chemoradiation of resected gastric cancer: a 10-year follow-up of the phase III trial INT0116 (SWOG 9008) Proc Am Soc Clin Oncol 27 2009 abstr 4515
54. Fuchs C, Tepper JE, Niedwiecki D, et al. Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (RT): interim toxicity results from Intergroup trial CALGB 80101. ASCO Gastrointestinal Cancers Symposium; San Francisco, CA, USA; Jan 26-28, 2006:abstr 61.
55. M. Stahl, M.K. Walz, and M. Stuschke Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
56. V. Gebski, B. Burmeister, B.M. Smithers, K. Foo, J. Zalcberg, J. Simes for the Australasian Gastro-Intestinal Trials Group Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234 (Pubitemid 46291702)
57. C. Mariette, G. Piessen, N. Briez, C. Gronnier, and J.P. Triboulet Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12 2011 296 305